BusinessAvid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease CandidateBy Nasdaq OMXMar 1, 2018, 1:05 PM UTC
BusinessAcumen and Martin Schoeller Launch #SeePeople Campaign to Change the Way the World Sees the PoorBy Nasdaq OMXOct 17, 2017, 2:44 PM UTC
